Product Liability Attorney Blog

It comes as no surprise that Yaz lawsuits are continuing to be filed on a regular basis; yet another Florida woman, Shana N. Vetter, and her husband, Wilson D. Enriquez, have filed a Yaz lawsuit.

The complaint was filed in the Southern District Court in Florida on September 20. Bayer Corporation, the makers of the popular but controversial oral contraceptive Yaz, is listed as a defendant along with Bayer Pharmaceuticals Inc., Bayer Healthcare LLC and Berlex Laboratories (which originated the manufacturing of Yaz).

Vetter’s case is similar to thousands of cases that were filed before hers in that she developed conditions as a result of taking the drosperinone-based pills. Vetter’s lawsuit claims that she has suffered from a pulmonary embolism, deep vein thrombosis and myocardial infarction after taking the drug. Her attorney states that Bayer and the other defendants “negligently designed, manufactured and distributed the contraceptives.” Vetter is asking for more than $75,000 in damages in her lawsuit.

The conditions mentioned in Vetter’s lawsuit are the same as those that are the subject of the upcoming bellwether trials (federal and state) which focus on Yaz and Yasmin’s side effects, and include pulmonary embolism, deep vein thrombosis and gallbladder disease. According to information listed in a Case Management Order that was issued by Judge David R. Herndon, who is presiding over the bellwether trials, “43 percent of plaintiffs suffered gallbladder disease, 40-41 percent experienced either pulmonary embolism or deep vein thrombosis and 9-10 percent were heart attack or stroke victims.”

There is much research to back up Vetter’s claims as to what caused her conditions and she is only one of thousands of women who have already filed suit. For its part, Bayer stubbornly refuses to accept liability and stands behinds its own study that found that there is no higher risk in taking contraceptives containing drosperinone than in taking older pills that contain levonorgestrel.